Amerita, Inc. is a Specialty Infusion company focused on providing complex pharmaceutical products and clinical services to patients outside of the hospital. This market is expanding rapidly and is driven by increasing healthcare costs that are moving patients into the most cost effective delivery settings, a growing bio-pharmaceutical pipeline of infuseable and injectable medications, an aging population and the recent addition of a Medicare benefit for these products and services.

What is Specialty Infusion?
Specialty infusion therapy services primarily involve the intravenous administration of medications that treat a wide range of acute and chronic health conditions such as infections, auto-immune illnesses, cancer, pain, multiple sclerosis, hemophilia and nutritional deficiencies.  To ensure quality, medications are compounded in a sterile clean room environment, dispensed under the supervision of a local registered pharmacist and delivered directly to the home of the patient.  Amerita then coordinates visits by a registered nurse, the frequency of which is dependent on the treatment type and the patient or caregiver's ability to safely administer the medication.  These drugs do not typically fit into the retail drug distribution model as they are high cost, may need special handling and require extensive patient training and/or administration by a clinician. Patients are generally referred by physicians, hospital discharge planners, home-health agencies and managed care organizations.

Our Strategy
We believe that specialty infusion is a local business.  We work closely with our referral sources to build the trust needed to service their complex patient’s needs outside of the hospital.  This trust can not be earned from a centralized or remote location.  Our local model assures the responsiveness, quality and personal touch that our customers expect. Our growth plan calls for the purchase of small to medium sized home infusion companies throughout the southern United States that have excellent clinical and service reputations.  After we purchase a company we invest in a growth plan that expands the geographic reach of the company as well as builds new clinical expertise in selected therapies.  We will also open new branches in selective markets that will increase our geographic coverage and our ability to service more patients across the country.  As we continue to grow we will take advantage of the purchasing and administrative efficiencies of a large company while keeping the entrepreneurial culture and local focus of a small company.  We believe this unique combination will allow us to effectively compete at the local, regional and national levels.